Target intelligence / Profile preview

Proinflammatory cytokine expression

Molecular classification
Other (signaling molecule, cytokine; sometimes grouped as interleukins, tumor necrosis factors, interferons, depending on the specific cytokine)
01

Overview

Proinflammatory cytokines are a group of signaling molecules secreted by immune cells, primarily T helper cells and macrophages, that promote and regulate inflammation. Major proinflammatory cytokines include interleukin-1 (IL-1), IL-6, tumor necrosis factor alpha (TNF-α), IL-12, and interferon gamma (IFN-γ). These cytokines facilitate the recruitment, activation, and proliferation of immune cells in response to infection or injury, but their excessive or prolonged expression contributes to numerous pathological states, including autoimmune disorders, chronic inflammation, and pain. Therapeutic targeting of specific proinflammatory cytokines (e.g., using monoclonal antibodies or receptor antagonists) is a mainstay in many inflammatory and autoimmune diseases. “Proinflammatory cytokine expression” describes a process (the increased production of these molecules) rather than any single, well-defined drug target or protein. For drug discovery or mechanistic studies, it is essential to specify the particular cytokine of interest (e.g., “Tumor necrosis factor alpha” or “Interleukin-6"), each of which is a structured and recognized target.

Other names
Inflammatory cytokinepro-inflammatory cytokineproinflammatory mediator
02

Mechanism of action

Blockade of cytokine or cytokine receptor; Neutralization of specific cytokines; Inhibition of cytokine signaling pathways

03

Biological functions

Immune responseInflammationSignal transductionCell activationPromotion of pathological pain
04

Disease associations

InflammationInfectionCancerNeurodegenerative diseaseCardiovascular diseaseAutoimmune disease
05

Safety considerations

Risk of immune suppression, leading to increased susceptibility to infectionPotential for cytokine release syndrome with excessive blockade or dysregulation
06

Interacting drugs

Monoclonal antibodies targeting individual cytokines (e.g., drugs targeting TNF-α, IL-1, IL-6)

1 more in the full profile.

07

Biomarkers

IL-6TNF-αIL-1βinterferon gammaCRP (C-reactive protein) for inflammation monitoring

Beyond the preview

Go deeper on Proinflammatory cytokine expression.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Proinflammatory cytokine expression.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call